Blomstrand, H., Green, H., Fredrikson, M., Gränsmark, E., Björnsson, B., & Elander, N. O. (2020). Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel. BMC Cancer.
Stile di citazione ChicagoBlomstrand, Hakon, Henrik Green, Mats Fredrikson, Emma Gränsmark, Bergthor Björnsson, e Nils O. Elander. "Clinical Characteristics and Blood/serum Bound Prognostic Biomarkers in Advanced Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel." BMC Cancer 2020.
Citazione MLABlomstrand, Hakon, et al. "Clinical Characteristics and Blood/serum Bound Prognostic Biomarkers in Advanced Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel." BMC Cancer 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.